Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro

Transfusion and Apheresis Science

Volumn 53, Issue 2, 2015, Pages 246-252

  Lin, Hsiu Chen ^a,b   Chang, Hui Wen ^b,c   Hsiao, Shun Hung ^c   Chou, Ming Li ^d   Seghatchian, Jerard ^e   Burnouf, Thierry ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

Author keywords

Aggregation; Monocytes; Platelet microparticles; THP; Thrombogenicity; Tissue factor

Indexed keywords

PROCOAGULANT; THROMBIN; THROMBOCYTE CONCENTRATE; THROMBOPLASTIN;

ARTICLE; CELL COUNTING; CELL SIZE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE AGGREGATION; LEUKOCYTE COUNT; MONOCYTE; MONOCYTE CULTURE; PHOTON CORRELATION SPECTROSCOPY; PLASMA; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; THROMBOCYTE ACTIVATION; TUNABLE RESISTIVE PULSE SENSING; CELL AGGREGATION; MEMBRANE MICROPARTICLE; METABOLISM; THROMBOCYTE; TUMOR CELL LINE;

BLOOD PLATELETS; CELL AGGREGATION; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; HUMANS; MONOCYTES; THROMBOPLASTIN;

EID: 84983146634     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.10.002     Document Type: Article

References (45)

1. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010, 78:838-848.
2. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
3. van der Pol E., Boing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012, 64:676-705.
4. Lynch S.F., Ludlam C.A. Plasma microparticles and vascular disorders. Br J Haematol 2007, 137:36-48.
5. van der Pol E., Coumans F., Varga Z., Krumrey M., Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost 2013, 11(Suppl. 1):36-45.
6. Gardiner C., Ferreira Y.J., Dragovic R.A., Redman C.W., Sargent I.L. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles 2013, 2.
7. Burnouf T., Goubran H.A., Chou M.L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28:155-166.
8. Mooberry M.J., Key N.S. Microparticle analysis in disorders of hemostasis and thrombosis. Cytometry A 2015, 10.1002/cyto.a.22647.
9. Gilbert G.E., Sims P., Wiedmer T., Furie B., Furie B., Shattil S. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991, 266:17261-17268.
10. Hoffman M., Monroe D., Roberts H. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 1992, 68:74-78.
11. Seghatchian J., Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997, 11:130-144.
12. Saas P., Angelot F., Bardiaux L., Seilles E., Garnache-Ottou F., Perruche S. Phosphatidylserine-expressing cell by-products in transfusion: a pro-inflammatory or an anti-inflammatory effect?. Transfus Clin Biol 2012, 19:90-97.
13. Lawrie A.S., Harrison P., Cardigan R.A., Mackie I.J. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008, 95:197-204.
14. Lawrie A.S., Cardigan R.A., Williamson L.M., Machin S.J., Mackie I.J. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008, 94:306-314.
15. Bode A.P., Orton S.M., Frye M.J., Udis B.J. Vesiculation of platelets during in vitro aging. Blood 1991, 77:887-895.
16. Krailadsiri P., Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, haemonetics MCS plus LD, and filtered pooled buffy-coat-derived platelets. Vox Sang 2000, 78:171-175.
17. Burnouf T., Chou M.L., Goubran H.A., Cognasse F., Garaud O., Seghatchian J. An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful?. Transfus Apher Sci 2015, 53(2):137-145.
18. Horstman L.L., Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999, 30:111-142.
19. Goubran H.A., Burnouf T., Stakiw J., Seghatchian J. Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease. Transfus Apher Sci 2015, 52:12-18.
20. Laffont B., Corduan A., Ple H., Duchez A.C., Cloutier N., Boilard E., et al. Activated platelets can deliver mRNA regulatory Ago2.microRNA complexes to endothelial cells via microparticles. Blood 2013, 122:253-261.
21. Brambilla M., Facchinetti L., Canzano P., Rossetti L., Ferri N., Balduini A., et al. Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation. Thromb Haemost 2015, 114:579-592.
22. Vasina E.M., Cauwenberghs S., Feijge M.A., Heemskerk J.W., Weber C., Koenen R.R. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011, 2:e211.
23. Milioli M., Ibanez-Vea M., Sidoli S., Palmisano G., Careri M., Larsen M.R. Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists. J Proteomics 2015, 121:56-66.
24. Aatonen M.T., Ohman T., Nyman T.A., Laitinen S., Gronholm M., Siljander P.R. Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 2014, 3.
25. Goubran H.A., Sabry W., Kotb R., Seghatchian J., Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015, 53(2):168-172.
26. Kriebardis A., Antonelou M., Stamoulis K., Papassideri I. Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?. Blood Transfus 2012, 10(Suppl. 2):s25-38.
27. Chou M.L., Lin L.T., Devos D., Burnouf T. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion 2015, 10.1111/trf.13162.
28. Burnouf T., Chou M.L., Wu Y.W., Su C.Y., Lee L.W. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion 2013, 53:138-146.
29. Laffont B., Corduan A., Ple H., Duchez A.C., Cloutier N., Boilard E., et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013, 122:253-261.
30. Cloutier N., Tan S., Boudreau L.H., Cramb C., Subbaiah R., Lahey L., et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 2013, 5:235-249.
31. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
32. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006, 20:1-26.
33. Cognasse F., Hamzeh-Cognasse H., Laradi S., Chou M.L., Seghatchian J., Burnouf T., et al. The role of microparticles in inflammation and transfusion: a concise review. Transfus Apher Sci 2015, 53(2):159-167.
34. Magee G., Inaba K., Chouliaras K., Strumwasser A., Matsushima K., Benjamin E.R., et al. Volume of red blood cells and plasma is associated with increased risk of venous thromboembolism in trauma patients. J Am Coll Surg 2014, 219:e190.
35. Zander A.L., Olson E.J., Van Gent J.-M., Bandle J., Calvo R.Y., Shackford S.R., et al. Does resuscitation with plasma increase the risk of venous thromboembolism?. J Trauma Acute Care Surg 2015, 78:39-44.
36. Abu-Rustum N.R., Richard S., Wilton A., Lev G., Sonoda Y., Hensley M.L., et al. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol 2005, 99:320-326.
37. Puetz J., Darling G., Brabec P., Blatny J., Mathew P. Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer 2009, 53:1074-1078.
38. Puetz J., Witmer C., Huang Y.S., Raffini L. Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect. J Pediatr 2012, 160:210-215.e1.
39. Connor D.E., Exner T., Ma D.D.F., Joseph J.E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010, 103:1044-1052.
40. Shai E., Rosa I., Parguina A.F., Motahedeh S., Varon D., Garcia A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012, 76. Spec No.:287-96.
41. Vachino G., Chang X.J., Veldman G.M., Kumar R., Sako D., Fouser L.A., et al. P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem 1995, 270:21966-21974.
42. Cerletti C., Tamburrelli C., Izzi B., Gianfagna F., de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb Res 2012, 129:263-266.
43. Krailadsiri P., Seghatchian J. Microvesicles in platelet concentrates 2000, Elsevier, Chapter 12.
44. Krailadsiri P., Seghatchian J., Bode A.P. Microvesicles in blood components: laboratory and clinical aspects. Clin Appl Thromb-Hem 1997, 3:86-95.
45. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011, 108:1284-1297.